• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
    • BOD
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Compliance

Compliance

Shareholding Pattern

Corporate Governance Report

Disclosures under sub-regulation (8) of Regulation 30 of LODR Regulations

Annual Secretarial Compliance Report: 2023-24

Details of the Familiarization Programme Imparted to Independent Director (ID)

Statement of Deviations or Variations as Specified in Regulation 32 of SEBI (LODR)

Related Party Transaction (RPT) Report

Copyrights Reserved 2008-2025. Naxpar Group